Meeting
2012 Genitourinary Cancers Symposium
Circulating tumor cells (CTCs) as a predictor of metastatic disease in patients with biochemical recurrence (BR) of prostate cancer with equivocal scan results.
Authors
Jeanny B. Aragon-Ching
George Washington University Medical Center, Washington, DC
Jeanny B. Aragon-Ching , Samuel J. Simmens , Steven R. Patierno , Robert S. Siegel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 239)
DOI
10.1200/jco.2012.30.5_suppl.239
Abstract #
239
Poster Bd #
D17
Abstract Disclosures
Similar Posters
Poster
2013 Genitourinary Cancers Symposium
Circulating tumor cells (CTCs) in biochemical recurrence (BR) of prostate cancer: Final results.
First Author: Jeanny B. Aragon-Ching
Poster
2011 Genitourinary Cancers Symposium
Role of circulating tumor cells (CTCs) in biochemical recurrence (BR) of prostate cancer.
First Author: Jeanny Aragon-Ching
Poster
2023 ASCO Genitourinary Cancers Symposium
Impact of MRI and targeted biopsy on oncological outcomes of prostate cancer after treatment.
First Author: Neha Debnath
Poster
2021 Genitourinary Cancers Symposium
PSA velocity to predict clinical progression in African American and non-Hispanic White patients with low-risk prostate cancer undergoing active surveillance.
First Author: Juan Javier-Desloges